🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/08/2022 | 65,01 | 65,01 | 61,27 | 61,59 | -5,78% | 5,76% | 232.595 |
| 25/08/2022 | 65,15 | 65,37 | 63,61 | 65,37 | +1,40% | 2,70% | 138.179 |
| 24/08/2022 | 62,90 | 65,07 | 62,28 | 64,47 | +1,72% | 4,44% | 106.600 |
| 23/08/2022 | 63,06 | 64,51 | 62,47 | 63,37 | +0,67% | 3,24% | 114.935 |
| 22/08/2022 | 63,43 | 64,26 | 62,50 | 62,95 | -1,74% | 2,77% | 161.262 |
| 19/08/2022 | 64,02 | 65,08 | 63,81 | 64,07 | -1,38% | 1,99% | 248.465 |
| 18/08/2022 | 65,77 | 65,77 | 63,74 | 64,97 | -1,79% | 3,09% | 102.752 |
| 17/08/2022 | 65,93 | 67,53 | 65,83 | 66,15 | -1,41% | 2,57% | 151.163 |
| 16/08/2022 | 66,27 | 67,50 | 65,07 | 67,10 | +0,23% | 3,67% | 172.803 |
| 15/08/2022 | 65,68 | 68,00 | 65,60 | 66,94 | +0,89% | 3,65% | 177.292 |
| 12/08/2022 | 63,74 | 66,56 | 63,74 | 66,35 | +4,31% | 4,41% | 139.782 |
| 11/08/2022 | 66,31 | 66,55 | 63,54 | 63,61 | -3,88% | 4,54% | 198.932 |
| 10/08/2022 | 65,65 | 66,18 | 63,86 | 66,18 | +3,31% | 3,54% | 174.887 |
| 09/08/2022 | 62,38 | 66,69 | 62,38 | 64,06 | +3,47% | 6,90% | 205.344 |
| 08/08/2022 | 60,70 | 62,27 | 59,83 | 61,92 | +2,18% | 4,03% | 211.436 |
| 05/08/2022 | 60,11 | 61,28 | 59,05 | 60,59 | -0,41% | 3,70% | 134.973 |
| 04/08/2022 | 59,26 | 61,07 | 58,65 | 60,84 | +2,94% | 4,10% | 176.971 |
| 03/08/2022 | 58,40 | 60,44 | 58,40 | 59,10 | +2,70% | 3,48% | 138.018 |
| 02/08/2022 | 55,41 | 58,22 | 55,06 | 57,55 | +2,84% | 5,71% | 134.171 |
| 01/08/2022 | 57,08 | 57,94 | 55,71 | 55,96 | -2,53% | 3,90% | 153.567 |
| 29/07/2022 | 58,34 | 58,34 | 56,76 | 57,41 | -2,05% | 2,72% | 126.477 |
| 28/07/2022 | 59,73 | 59,78 | 57,44 | 58,62 | -1,87% | 3,92% | 115.737 |
| 27/07/2022 | 58,58 | 60,03 | 57,39 | 59,73 | +3,52% | 4,50% | 172.002 |
| 26/07/2022 | 57,23 | 58,19 | 56,43 | 57,70 | -0,06% | 3,08% | 111.889 |
| 25/07/2022 | 57,18 | 57,80 | 56,79 | 57,74 | +1,40% | 1,78% | 84.959 |
| 22/07/2022 | 59,09 | 59,09 | 56,64 | 56,94 | -4,07% | 4,14% | 151.484 |
| 21/07/2022 | 59,45 | 59,90 | 58,93 | 59,35 | +0,43% | 1,63% | 96.661 |
| 20/07/2022 | 58,02 | 59,89 | 57,75 | 59,10 | +1,55% | 3,68% | 197.329 |
| 19/07/2022 | 57,84 | 59,13 | 57,61 | 58,19 | +2,52% | 2,63% | 182.902 |
| 18/07/2022 | 59,26 | 60,04 | 56,39 | 56,76 | -3,74% | 6,16% | 253.755 |